Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Oct 22;17:1536012118795728. doi: 10.1177/1536012118795728

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — A, Representative [¹⁸F]FDG PET/CT images in control and BLM groups at day 21 after instillation. (The red arrows indicate fibrotic lung tissues.) B, The lung uptake of [¹⁸F]FDG in control and BLM groups at 1 hour after injection. C, The lung versus muscle uptake ratio of [¹⁸F]FDG in 2 groups. D, The uptake of fibrotic lung tissues between [¹⁸F]FDG and [¹⁸F]ML-8 in the BLM group. E, Bar chart shows difference in the uptake ratio (lung versus muscle) between [¹⁸F]ML-8 PET and [¹⁸F]FDG PET at day 21 after instillation. Data are reported as mean (standard deviation; N = 3 for each group).*P < .05. BLM indicates bleomycin; CT, computed tomography; [¹⁸F]FDG, ¹⁸F-fluorodeoxyglucose; [¹⁸F]ML-8; 2-(3-[¹⁸F]fluoropropyl)-2-methyl-malonic acid; PET, positron emission tomography.